4.7 Review

COVID-19 in early 2021: current status and looking forward

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Infectious Diseases

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial

Shengli Xia et al.

Summary: The inactivated SARS-CoV-2 vaccine, BBIBP-CorV, demonstrated safety and immunogenicity in two age groups. Humoral responses against SARS-CoV-2 were induced in all vaccine recipients by day 42. A two-dose immunisation with 4 mu g vaccine on days 0 and 21 or days 0 and 28 achieved higher neutralising antibody titres compared to other dosing schedules.

LANCET INFECTIOUS DISEASES (2021)

Review Infectious Diseases

The epidemiological and radiographical characteristics of asymptomatic infections with the novel coronavirus (COVID-19): A systematic review and meta-analysis

Can Chen et al.

Summary: A meta-analysis on asymptomatic COVID-19 infections revealed that they were more common in children and healthcare workers, and increased after February 29, 2020, especially in non-Asian regions. Chest radiographical imaging could help in the early identification of asymptomatic infections.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

Article Medicine, General & Internal

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey et al.

Summary: The ChAdOx1 nCoV-19 vaccine has been shown to have an acceptable safety profile and effectiveness against symptomatic COVID-19, with higher efficacy observed in the group that received a low dose followed by a standard dose.

LANCET (2021)

Review Medicine, General & Internal

Maintaining Safety with SARS-CoV-2 Vaccines

Mariana C. Castells et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Medicine, General & Internal

A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19

Oriol Mitja et al.

Summary: In a trial involving asymptomatic contacts of patients with PCR-confirmed Covid-19 in Spain, the authors compared the use of hydroxychloroquine with usual care. Postexposure therapy with hydroxychloroquine did not prevent SARS-CoV-2 infection or symptomatic Covid-19 in healthy persons.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Medicine, General & Internal

Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia

Denis Y. Logunov et al.

Summary: The Gam-COVID-Vac vaccine showed 91.6% efficacy against COVID-19 in the phase 3 trial, with good safety and tolerability in a large cohort of participants.

LANCET (2021)

Article Infectious Diseases

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

Yanjun Zhang et al.

Summary: This study investigated the safety, tolerability, and immunogenicity of the COVID-19 vaccine candidate CoronaVac, and found that the 3 μg dose showed higher seroconversion rates in the phase 2 trial.

LANCET INFECTIOUS DISEASES (2021)

Article Multidisciplinary Sciences

SARS-CoV-2 evolution during treatment of chronic infection

Steven A. Kemp et al.

Summary: Chronic infection with SARS-CoV-2 can lead to viral evolution and increased resistance to neutralizing antibodies in immunosuppressed individuals treated with convalescent plasma. During convalescent plasma therapy, there were significant shifts in the viral population structure and sensitivity, suggesting strong selection pressure on the virus during treatment.

NATURE (2021)

Article Immunology

Consistent Detection of 2019 Novel Coronavirus in Saliva

Kelvin Kai-Wang To et al.

CLINICAL INFECTIOUS DISEASES (2020)

Article Medicine, General & Internal

Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore

Barnaby Edward Young et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Editorial Material Medicine, General & Internal

Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury

Clark D. Russell et al.

LANCET (2020)

Article Medicine, General & Internal

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Chaolin Huang et al.

LANCET (2020)

Article Infectious Diseases

A family cluster of SARS-CoV-2 infection involving 11 patients in Nanjing, China

Rui Huang et al.

LANCET INFECTIOUS DISEASES (2020)

Letter Infectious Diseases

An interactive web-based dashboard to track COVID-19 in real time

Ensheng Dong et al.

LANCET INFECTIOUS DISEASES (2020)

Article Medicine, General & Internal

Clinical Characteristics of Coronavirus Disease 2019 in China

W. Guan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

First Case of 2019 Novel Coronavirus in the United States

Michelle L. Holshue et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

A Novel Coronavirus from Patients with Pneumonia in China, 2019

Na Zhu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia

Qun Li et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Multidisciplinary Sciences

Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2

Renhong Yan et al.

SCIENCE (2020)

Letter Critical Care Medicine

Tobacco Smoking Increases the Lung Gene Expression of ACE2, the Receptor of SARS-CoV-2

Guoshuai Cai et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)

News Item Medicine, General & Internal

Coronavirus: covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate

Elisabeth Mahase

BMJ-BRITISH MEDICAL JOURNAL (2020)

Article Immunology

Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)

Li Guo et al.

CLINICAL INFECTIOUS DISEASES (2020)

Article Infectious Diseases

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial

Philippe Gautret et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)

Editorial Material Medicine, General & Internal

Convalescent Plasma to Treat COVID-19 Possibilities and Challenges

John D. Roback et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Medicine, General & Internal

Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma

Chenguang Shen et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Medicine, General & Internal

Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State

Eli S. Rosenberg et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Letter Medicine, General & Internal

Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State

Matt Arentz et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Multidisciplinary Sciences

Phylogenetic network analysis of SARS-CoV-2 genomes

Peter Forster et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Article Multidisciplinary Sciences

Changes incontact patterns shape the dynamics of the COVID-19 outbreak in China

Juanjuan Zhang et al.

SCIENCE (2020)

Article Multidisciplinary Sciences

Development of an inactivated vaccine candidate for SARS-CoV-2

Qiang Gao et al.

SCIENCE (2020)

Article Multidisciplinary Sciences

Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period

Stephen M. Kissler et al.

SCIENCE (2020)

Editorial Material Medicine, General & Internal

Face masks for the public during the covid-19 crisis

Trisha Greenhalgh et al.

BMJ-BRITISH MEDICAL JOURNAL (2020)

Article Medicine, General & Internal

Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study

Tao Chen et al.

BMJ-BRITISH MEDICAL JOURNAL (2020)

Article Public, Environmental & Occupational Health

Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) - United States, February 12-March 16, 2020

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)

Editorial Material Biochemistry & Molecular Biology

Preparing for a responsible lockdown exit strategy

Marius Gilbert et al.

NATURE MEDICINE (2020)

Article Biochemistry & Molecular Biology

Artificial intelligence-enabled rapid diagnosis of patients with COVID-19

Xueyan Mei et al.

NATURE MEDICINE (2020)

Editorial Material Biochemistry & Molecular Biology

Digital technology and COVID-19

Daniel Shu Wei Ting et al.

NATURE MEDICINE (2020)

Article Biochemistry & Molecular Biology

Modelling the COVID-19 epidemic and implementation of population-wide interventions in Italy

Giulia Giordano et al.

NATURE MEDICINE (2020)

Article Biochemistry & Molecular Biology

Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19

Mingfeng Liao et al.

NATURE MEDICINE (2020)

Letter Medicine, General & Internal

Visualizing Speech-Generated Oral Fluid Droplets with Laser Light Scattering

Philip Anfinrud et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

Epidemiology of Covid-19 in a Long-Term Care Facility in King County, Washington

Temet M. McMichael et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Pediatrics

Epidemiology of COVID-19 Among Children in China

Yuanyuan Dong et al.

PEDIATRICS (2020)

Editorial Material Cell Biology

Artificial intelligence and machine learning to fight COVID-19

Ahmad Alimadadi et al.

PHYSIOLOGICAL GENOMICS (2020)

Article Medical Laboratory Technology

Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis

Giuseppe Lippi et al.

CLINICA CHIMICA ACTA (2020)

Review Medicine, General & Internal

Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19) A Review

W. Joost Wiersinga et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Medicine, General & Internal

Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes Interim Analysis of 2 Randomized Clinical Trials

Shengli Xia et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Infectious Diseases

Estimates of the severity of coronavirus disease 2019: a model-based analysis

Robert Verity et al.

LANCET INFECTIOUS DISEASES (2020)

Article Multidisciplinary Sciences

Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults

Mark J. Mulligan et al.

NATURE (2020)

Article Biochemistry & Molecular Biology

Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China

Xin Xu et al.

NATURE MEDICINE (2020)

Article Medicine, General & Internal

An mRNA Vaccine against SARS-CoV-2-Preliminary Report

L. A. Jackson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19

Peter Horby et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

Edward E. Walsh et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults

E. J. Anderson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine

Cheryl Keech et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Letter Medicine, Research & Experimental

SARS-CoV-2 reinfection in two patients who have recovered from COVID-19

Kang Zhang et al.

PRECISION CLINICAL MEDICINE (2020)

Review Immunology

Immunological considerations for COVID-19 vaccine strategies

Mangalakumari Jeyanathan et al.

NATURE REVIEWS IMMUNOLOGY (2020)

Article Medicine, Research & Experimental

A precision medicine approach to managing 2019 novel coronavirus pneumonia

Minjin Wang et al.

PRECISION CLINICAL MEDICINE (2020)

Article Pediatrics

Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. Interim guidance

[Anonymous]

PEDIATRIA I MEDYCYNA RODZINNA-PAEDIATRICS AND FAMILY MEDICINE (2020)

Article Multidisciplinary Sciences

Inhibition of novel β coronavirus replication by a combination of interferon- α2b and ribavirin

Darryl Falzarano et al.

SCIENTIFIC REPORTS (2013)